Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus.

Elaine WongRebecca CopeLorena DimaTimothy Nguyen

Published in: American journal of therapeutics (2022)

Tirzepatide is a novel first in class dual GIP and glucagon-like peptide-1 agonist that improves overall glycemic control as an adjunct to diet and exercise. It has the potential benefits in other therapeutic areas such as obesity.

Keyphrases

glycemic control
weight loss
type diabetes
blood glucose
insulin resistance
physical activity
metabolic syndrome
high intensity
blood pressure
high fat diet induced
skeletal muscle
human health
risk assessment
body composition
body mass index
climate change